P+P advised Equistone on the sale of Sunrise Medical
Funds advised by Equistone Partners Europe sold their majority shareholding in Sunrise Medical Group to Nordic Capital Fund VII.
Equistone acquired a majority stake in Sunrise Medical by way of a secondary buyout in November 2012. The purchase price was not disclosed. The transaction is still subject to approval by the antitrust authorities.
Sunrise Medical is one of the world leaders in the development, production and distribution of manual wheelchairs, electric wheelchairs, electric cars and systems for seats and positioning.
P+P Pöllath + Partners advised Equistone on the legal aspects of the sale with the following interdisciplinary team:
- Dr. Andrea von Drygalski (lead, partner, M&A, Munich)
- Dr. Benedikt Hohaus (partner, MPP, Munich)
- Dr. Tim Kaufhold (counsel, M&A, Munich)
- Stefan Benz (associate, M&A, Munich)
- Andrea Beilborn (associate, M&A, Munich)
In addition, Hans-Jürgen Meyer-Lindemann and Clemens Graf York von Wartenburg of Dechert LLP advised the sellers on antitrust matters.
On the buyer's side, Dr. Stefan Koch, Dr. Markus Stephanblome and Daniel David (all M&A) of White & Case advised Nordic Capital Fund VII.
